Biomaterial wound dressing market to hit $8.62 billion by 2030

The biomaterial wound dressing market is projected to grow from $6.18 billion in 2025 to $6.65 billion in 2026, with North America holding the largest share and Asia-Pacific expected to grow fastest. The report points to rising surgical volumes, chronic and diabetic wounds, and wider use of advanced dressings in hospitals, clinics and home care.

Why it matters: - Biomaterial wound dressings are becoming more important as wound care shifts toward products that support faster healing, infection control and tissue regeneration. - The market's growth signals rising demand from hospitals, clinics, home care and ambulatory settings. - The report says the category is also expanding because of more burns, traumatic injuries, chronic wounds and diabetic wounds.

What happened: - The Business Research Company published an update on the biomaterial wound dressing market on July 29, 2026. - The market is projected to rise from $6.18 billion in 2025 to $6.65 billion in 2026. - The report forecasts the market will reach $8.62 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - The 2025-2026 growth rate is 7.6%. - The 2026-2030 growth rate is forecast at 6.7%. - Historical growth has been driven by more burns and traumatic injuries, more hospitalizations for chronic and diabetic wounds, early adoption of hydrogel and alginate dressings, tighter infection control, and expanding wound care services. - Future growth is expected to come from an aging population, higher rates of pressure ulcers, demand for bioengineered skin substitutes, and wider use of advanced dressings in home and ambulatory care. - Biomaterial wound dressings are made from natural or synthetic substances compatible with human tissue. - These dressings are designed to cover and protect wounds, support healing and create an environment that helps tissue regenerate. - Some products add antibacterial action, moisture retention and closer fit to wound surfaces. - The report highlights growing interest in dressings that maintain optimal moisture levels. - Antibacterial and antimicrobial dressings are seeing greater adoption for chronic wounds, burns and pressure ulcers. - Product innovation is focused on biocompatibility, comfort and tissue regeneration. - Biomaterial dressings are also being used more often in surgical and post-operative care. - A free sample of the report is available at the company's sample page. - The full report is available at the full market report.

Between the lines: - Rising surgical volumes are a major demand driver because biomaterial dressings help protect surgical sites from infection and lower complication risk. - Australian public hospitals admitted 778,500 elective surgery patients in 2023-24, up 5.8% from the prior year, according to data cited from the Australian Institute of Health and Welfare. - The report's emphasis on moisture control and antimicrobial features suggests buyers are prioritizing clinical performance over basic wound coverage. - The regional split points to a mature North American market and a faster-growing opportunity in Asia-Pacific.

What's next: - The market is expected to keep expanding as aging populations increase pressure ulcer cases and as advanced wound care moves further into non-hospital settings. - Demand for bioengineered skin substitutes and advanced dressings is likely to shape product development through 2030. - The report also adds 2026 features including market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, hotspots infographics and updated graphics and tables.

The bottom line: - Biomaterial wound dressings are moving from a niche wound-care product to a larger, more technology-driven market with the strongest growth ahead in Asia-Pacific and in advanced care settings.